心血管病理学,诊断和治疗中的长非编码RNA
Christian Bär1, Shambhabi Chatterjee1, Thomas Thum2
1From Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
Circulation
|November 9, 2016
概括
长非编码RNAs (lncRNAs) 是基因表达的关键调节者,在细胞过程中发挥着不同的作用. 本综述探讨它们在心脏发育和疾病中的功能,强调它们作为心脏衰竭的生物标志物和治疗点的潜力.
科学领域:
- 基因组学
- 分子生物学
- 心血管科学
背景情况:
- 哺乳动物的基因组包含许多非蛋白质编码转录,长非编码RNA (lncRNAs),其功能长期不清楚.
- 新出现的证据显示 lncRNAs 具有动态表达,并在各种细胞环境中发挥关键的调节作用.
研究的目的:
- 审查 lncRNA 的多方面功能,重点关注它们在心脏发育和疾病中的作用.
- 评估 lncRNAs 作为诊断生物标志物和心血管疾病,特别是心力衰竭的治疗点的潜力.
主要方法:
- 对 lncRNA 功能的当前研究进行文献综述.
- 强调与心脏发育,生理学和病理学相关的研究.
- 探索 lncRNA 在表观遗传修饰,替代拼接和分子海绵中的参与.
主要成果:
- lncRNAs在多个层面上表现出不同的调节作用.
- 它们在心血管系统中的丰富性表明它们在心脏调节网络中起着重要作用.
- 在正常的心脏功能和心脏病的进展中都涉及到 lncRNAs.
结论:
- lncRNAs是基因调节的组成部分,对心血管健康有重大影响.
- lncRNAs的独特表达模式和调节功能为心脏病学中的新诊断和治疗策略提供了有前途的途径.
- 进一步研究 lncRNA 可能会彻底改变心力衰竭和其他心血管疾病的治疗方法.
相关概念视频
lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs
3.8K
3.8K
Cardiomyopathy I: Introduction and Classification
744
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
744
Coronary Artery Disease II: Pathophysiology
862
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
862
Cardiomyopathy IV: Restrictive Cardiomyopathy
714
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
714
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.1K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K

